Page last updated: 2024-08-16

tibolone and Cancer of Ovary

tibolone has been researched along with Cancer of Ovary in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Brusselaers, N; Callens, S; Engstrand, L; Simin, J; Tamimi, RM1
Altwerger, G; Black, J; Feinberg, J; Menderes, G; Ratner, E; Whicker, M1
Løkkegaard, ECL; Mørch, LS1
Dyba, T; Koskela-Niska, V; Lyytinen, H; Pukkala, E; Ylikorkala, O1
Huang, H; Pan, L; Shen, K; Wen, Y; Wu, M1
Neves-E-Castro, M1
Chatzigeorgiou, K; Goulis, D; Pantazis, K; Papanicolaou, A; Tarlatzis, BC; Theodoridis, TD; Vavilis, D1
Lee, JM; Lee, KB; Park, CY; Yoon, JH1
Kimmig, R; Schmidt, M1

Reviews

3 review(s) available for tibolone and Cancer of Ovary

ArticleYear
Management of sexuality, intimacy, and menopause symptoms in patients with ovarian cancer.
    American journal of obstetrics and gynecology, 2017, Volume: 217, Issue:4

    Topics: Administration, Topical; Anabolic Agents; Body Image; Cognitive Behavioral Therapy; Depression; Estrogen Antagonists; Estrogens; Fatigue; Female; Hormone Replacement Therapy; Humans; Lubricants; Menopause, Premature; Norpregnenes; Ovarian Neoplasms; Pelvic Floor Disorders; Physical Therapy Modalities; Phytotherapy; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sexuality; Tamoxifen; Testosterone

2017
Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
    Clinical obstetrics and gynecology, 2008, Volume: 51, Issue:3

    Topics: Estrogen Replacement Therapy; Estrogens; Female; Humans; Norpregnenes; Ovarian Neoplasms; Postmenopause; Progestins; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms

2008
[The benefits and risks of hormonal replacement therapy--an update].
    Gynakologisch-geburtshilfliche Rundschau, 2006, Volume: 46, Issue:4

    Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cardiovascular Diseases; Colonic Neoplasms; Dementia; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Meta-Analysis as Topic; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Primary Prevention; Progestins; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Time Factors

2006

Other Studies

6 other study(ies) available for tibolone and Cancer of Ovary

ArticleYear
Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
    International journal of cancer, 2020, 07-01, Volume: 147, Issue:1

    Topics: Aged; Carcinoma, Ovarian Epithelial; Cohort Studies; Estrogens; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Ovarian Neoplasms; Progestins; Prospective Studies; Risk; Sweden

2020
Tibolone and risk of gynecological hormone sensitive cancer.
    International journal of cancer, 2018, 06-15, Volume: 142, Issue:12

    Topics: Aged; Denmark; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Humans; Incidence; Middle Aged; Norpregnenes; Ovarian Neoplasms

2018
Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.
    International journal of cancer, 2013, Oct-01, Volume: 133, Issue:7

    Topics: Aged; Aged, 80 and over; Case-Control Studies; Contraceptive Agents, Female; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Finland; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Ovarian Neoplasms; Postmenopause; Progestins; Registries; Risk

2013
The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China.
    Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Carcinoma, Ovarian Epithelial; Case-Control Studies; China; Disease-Free Survival; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogens; Hormone Replacement Therapy; Humans; Kaplan-Meier Estimate; Menopause, Premature; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Norpregnenes; Ovarian Neoplasms; Postoperative Period; Proportional Hazards Models; Retrospective Studies; Survival Rate; Young Adult

2013
Hormonal replacement therapy in ovarian cancer survivors: a survey among Greek gynecologists.
    European journal of gynaecological oncology, 2011, Volume: 32, Issue:5

    Topics: Antineoplastic Agents, Hormonal; Attitude of Health Personnel; Diphosphonates; Estrogens; Female; Greece; Gynecology; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Ovarian Neoplasms; Phytoestrogens; Prescriptions; Progestins; Surveys and Questionnaires

2011
The safety of tibolone in epithelial ovarian cancer patients.
    Maturitas, 2006, Sep-20, Volume: 55, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Case-Control Studies; Chi-Square Distribution; Climacteric; Disease-Free Survival; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Multivariate Analysis; Neoplasms, Glandular and Epithelial; Norpregnenes; Ovarian Neoplasms; Proportional Hazards Models; Retrospective Studies; Treatment Outcome

2006